Standard Biotools (LAB) Capital Expenditures Growth (5y) (2015 - 2026)
Standard Biotools (LAB) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Standard Biotools | 258.10 Mn | -218.62 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50.08% |
| Mar 31, 2026 | -45.96% |
| Dec 31, 2025 | -41.78% |
| Sep 30, 2025 | -16.45% |
| Jun 30, 2025 | -57.20% |
| Mar 31, 2025 | 37.45% |
| Dec 31, 2024 | -52.76% |
| Sep 30, 2024 | 29.87% |
| Jun 30, 2024 | -31.04% |
| Mar 31, 2024 | 24.04% |
| Dec 31, 2023 | -168.54% |
| Sep 30, 2023 | 35.52% |
| Jun 30, 2023 | 61.19% |
| Mar 31, 2023 | 67.33% |
| Dec 31, 2022 | 33.51% |
| Sep 30, 2022 | 17.94% |
| Jun 30, 2022 | 45.88% |
| Mar 31, 2022 | 4.64% |
| Dec 31, 2021 | -6.35% |
| Sep 30, 2021 | 49.59% |